Mast cell membrane-associated targets

Mast cell membrane-associated targets encompass a diverse group of surface-expressed receptors and proteins that regulate the activation, degranulation, and survival of mast cells. These targets are central to the immune system's response to allergens and pathogens, but their dysregulation is a hallmark of allergic diseases, asthma, systemic mastocytosis, and mast cell activation syndrome (MCAS). Key targets within this category include the high-affinity IgE receptor (FcεRI), which triggers the release of inflammatory mediators like histamine and tryptase upon allergen cross-linking; the KIT receptor (CD117), which is essential for mast cell development and survival; and the Mas-related G protein-coupled receptor member X2 (MRGPRX2), which mediates non-IgE-dependent activation. Additionally, inhibitory receptors such as Siglec-8 and CD200R serve as regulatory "brakes" to suppress mast cell activity. Therapeutic strategies targeting these molecules include monoclonal antibodies that block IgE binding or activate inhibitory pathways, as well as small-molecule kinase inhibitors that target KIT signaling to treat mast cell-driven pathologies.

Other names

Mast cell surface receptorsMast cell membrane proteinsMast cell activation targetsMast cell surface markers

Modulation of mast cell activity through various mechanisms: blocking IgE-mediated activation (FcεRI), inhibiting growth and survival signaling (KIT), activating inhibitory pathways (Siglec-8), or stabilizing the cell membrane to prevent degranulation (Cromolyn).